ADVISORS ASSET MANAGEMENT, INC. – Regeneron Pharmaceuticals, Inc. Transaction History
ADVISORS ASSET MANAGEMENT, INC. portfolio value:
$5.43M
portfolio value
ADVISORS ASSET MANAGEMENT, INC. quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -1.79% | -144 shares | 686K | $688.87 | 7.88K |
| Q2 2022 | share | Decrease | -7.90% | -689 shares | -1.34M | $591.13 | 8.03K |
| Q1 2022 | share | Decrease | -19.34% | -2.09K shares | -737K | $698.42 | 8.72K |
| Q4 2021 | share | Decrease | -19.64% | -2.64K shares | -1.31M | $642.51 | 10.81K |
| Q3 2021 | share | Decrease | -4.61% | -650 shares | 264K | $605.18 | 13.45K |
| Q2 2021 | share | Decrease | -17.00% | -2.88K shares | -162K | $558.54 | 14.10K |
| Q1 2021 | share | Decrease | -21.76% | -4.72K shares | -2.45M | $473.14 | 16.99K |
| Q4 2020 | share | Decrease | -2.41% | -537 shares | -1.96M | $483.11 | 21.71K |
| Q3 2020 | share | Decrease | -4.76% | -1.11K shares | -2.11M | $559.78 | 22.25K |
| Q2 2020 | share | Increase | +7.37% | 1.60K shares | 3.94M | $623.65 | 23.36K |
| Q1 2020 | share | Increase | +4.70% | 978 shares | 2.82M | $488.29 | 21.76K |
| Q4 2019 | share | Increase | +18.85% | 3.29K shares | 2.95M | $375.48 | 20.78K |
| Q3 2019 | share | Increase | +28.84% | 3.91K shares | 603K | $277.4 | 17.49K |
| Q2 2019 | share | Increase | +39.56% | 3.84K shares | 255K | $313 | 13.57K |
| Q1 2019 | share | Increase | +34.18% | 2.47K shares | 1.28M | $410.62 | 9.72K |
| Q4 2018 | share | Increase | +87.26% | 3.37K shares | 1.14M | $373.5 | 7.24K |
| Q3 2018 | share | Decrease | -22.05% | -1.09K shares | -149K | $404.04 | 3.87K |
| Q2 2018 | share | Decrease | -28.66% | -1.99K shares | -518K | $344.99 | 4.96K |
| Q1 2018 | share | Decrease | -1.19% | -84 shares | -418K | $344.36 | 6.96K |
| Q4 2017 | share | Increase | +2.89% | 198 shares | -412K | $375.96 | 7.04K |
| Q3 2017 | share | Decrease | -11.08% | -853 shares | -721K | $447.12 | 6.84K |
| Q2 2017 | share | Increase | +45.17% | 2.39K shares | 1.72M | $491.14 | 7.7K |
| Q1 2017 | share | Decrease | -27.11% | -1.97K shares | -616K | $387.51 | 5.30K |
| Q4 2016 | share | Increase | +1.56% | 112 shares | -209K | $367.09 | 7.27K |
| Q3 2016 | share | Decrease | -19.49% | -1.73K shares | -228K | $402.02 | 7.16K |
| Q2 2016 | share | Decrease | -5.24% | -492 shares | -277K | $349.23 | 8.9K |
| Q1 2016 | share | Decrease | -30.08% | -4.04K shares | -3.90M | $360.44 | 9.39K |